title: Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma.
abstract: In the February 2011 issue of Endocrine-Related Cancer, Deandreis et al. reported that increased FDG uptake was prognostic in patients with metastatic thyroid cancer. Fludeoxyglucose-positron emission tomography (FDG-PET) is routinely used in the staging and follow-up of patients with cancer. This study gives further evidence for the role of FDG-PET scanning in metastatic thyroid cancer, especially to identify patients with aggressive disease requiring systemic therapy.
authors.affiliation: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. mcabani@mdanderson.org
authors.forename: Maria E
authors.initials: ME
authors.lastname: Cabanillas
authors.forename: Steven I
authors.initials: SI
authors.lastname: Sherman
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics*; D008297:Male
chemical_list: D007457:Iodine Radioisotopes; D019788:Fluorodeoxyglucose F18